Glyxambi 10mg/5mg Tablet (Empagliflozin and Linagliptin )

Prescription only Brand
$95.08
Active Ingredient : Empagliflozin and Linagliptin
Empagliflozin and Linagliptin is a prescription medication designed to help manage blood sugar levels in adults with type 2 diabetes. This combination medication works by enhancing insulin sensitivity and reducing glucose production, aiding in effective b

Reliable shipping

Flexible returns

Dispensing Country : India
Zoomed

Glyxambi 10mg/5mg Tablet is a prescription medication that combines two active ingredients, Empagliflozin and Linagliptin, to effectively manage type 2 diabetes. This combination works by targeting different mechanisms in the body, helping to lower blood sugar levels.



Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases insulin secretion and decreases glucagon levels, particularly after meals. Together, these components provide a comprehensive approach to blood sugar control.



Key benefits of Glyxambi include:



  • Improved glycemic control in adults with type 2 diabetes.

  • Reduced risk of cardiovascular events in patients with established heart disease.

  • Convenient once-daily dosing.

  • Potential weight loss benefits associated with SGLT2 inhibitors.



It is important for patients to follow their healthcare provider's instructions regarding dosage and administration. Regular monitoring of blood sugar levels is essential to ensure optimal results and to adjust treatment as necessary. Glyxambi is not recommended for individuals with a history of severe kidney problems or those who are allergic to its components.



In summary, Glyxambi 10mg/5mg Tablet is an effective treatment option for managing type 2 diabetes, offering a dual-action approach that can lead to better overall health outcomes.


  • Empagliflozin

  • Linagliptin

Glyxambi 10mg/5mg Tablet contains two active ingredients, Empagliflozin and Linagliptin, which work together to help manage blood sugar levels in adults with type 2 diabetes. To use this medication effectively, follow these detailed instructions:




  • Consult Your Doctor: Before beginning treatment with Glyxambi, discuss your medical history with your healthcare provider. Inform them of any other medications you are currently taking, as well as any existing health conditions.

  • Dosage: The typical starting dose for adults is one tablet taken once daily. It’s essential to take Glyxambi at the same time each day to maintain consistent blood levels of the medication.

  • Administration: Take the tablet whole with a glass of water. Do not crush or chew the tablet, as this may affect how the medication works in your body.

  • With or Without Food: Glyxambi can be taken with or without food. However, it is advisable to take it consistently either way to avoid fluctuations in absorption.

  • Missed Dose: If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once.

  • Monitoring: Regularly monitor your blood sugar levels as directed by your doctor. This will help you and your healthcare team assess how well the medication is working.

  • Side Effects: Be aware of potential side effects, which may include nausea, diarrhea, or low blood sugar. Contact your doctor if you experience severe side effects or symptoms of an allergic reaction.

  • Hydration: Stay well-hydrated while taking this medication, as Empagliflozin can increase urination, which may lead to dehydration.

  • Regular Check-ups: Schedule regular check-ups with your healthcare provider to monitor your diabetes management and adjust your treatment plan if necessary.

  • Storage: Store Glyxambi at room temperature, away from moisture and heat. Keep it out of reach of children.



Always follow your healthcare provider's specific instructions regarding the use of Glyxambi and report any concerns or questions you may have during your treatment.

You may also like